High-profile Beverly Hills med spa signals confidence in RF microneedling and injectables as core revenue drivers.
Beverly Wilshire Aesthetics, a Beverly Hills medical spa, has announced a global rebrand and expanded service menu centered on Botox, dermal fillers, and Morpheus8 RF microneedling. The rebrand signals a deliberate shift toward injectables and energy-device treatments as the practice's revenue backbone.
Morpheus8 adoption by high-visibility practices in premium markets validates the device's clinical efficacy and patient demand. The combination of fractional RF microneedling with radiofrequency energy delivers skin tightening and texture improvement—outcomes that justify premium pricing in markets like Beverly Hills. Practices adding Morpheus8 typically see per-treatment margins of 60–70% after device amortization.
Premium practices anchor rebrands around Morpheus8 and injectables.
The rebrand also reflects a broader trend: aesthetic practices are shedding generic "med spa" branding in favor of specific clinical capabilities. Naming Morpheus8 and injectables explicitly signals sophistication to affluent patients and differentiates from commodity laser-and-wax clinics.
Source: original report ↗
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
